Xp11.2 Translocation-Related Renal Cell Carcinoma
1 clinical trials · Condition
◉ Watch Xp11.2 Translocation-Related Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) (NCT03685448) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2019-04-11 |
Track Xp11.2 Translocation-Related Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.